Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PH1”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Testing effectiveness (Phase 2)Looking for participantsNCT04115306
What this trial is testing

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Phoenix Molecular Designs 61
Early research (Phase 1)Study completedNCT07518771
What this trial is testing

PA-001 Ph.1 Study in Healthy and Elderly Subjects

Who this might be right for
COVID - 19
PeptiDream Inc. 47
Early research (Phase 1)Study completedNCT03574142
What this trial is testing

A Ph 1 Study of Epanova® in Healthy Chineses

Who this might be right for
Healthy Subjects
AstraZeneca 14
Testing effectiveness (Phase 2)Looking for participantsNCT04580420
What this trial is testing

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Who this might be right for
Primary Hyperoxaluria Type 1End Stage Renal Disease
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 28
Early research (Phase 1)Study completedNCT00678652
What this trial is testing

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine

Who this might be right for
Meningococcal Infection, Group B
U.S. Army Medical Research and Development Command 36
Testing effectiveness (Phase 2)Looking for participantsNCT07002398
What this trial is testing

Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)

Who this might be right for
Retinal Dystrophy Due to Biallelic ABCA4 MutationsStargardt Disease 1
VeonGen Therapeutics GmbH 15
Early research (Phase 1)Study completedNCT02209766
What this trial is testing

A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

Who this might be right for
Healthy
AstraZeneca 86
Early research (Phase 1)Ended earlyNCT02795325
What this trial is testing

DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 41
Early research (Phase 1)Study completedNCT00412412
What this trial is testing

CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study

Who this might be right for
Breast Cancer
Biogen 34
Not applicableLooking for participantsNCT02026388
What this trial is testing

Rare Kidney Stone Consortium Biobank

Who this might be right for
Primary HyperoxaluriaDent DiseaseAPRT Deficiency+1 more
Mayo Clinic 2,000
Large-scale testing (Phase 3)Study completedNCT04152200
What this trial is testing

Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1Primary Hyperoxaluria
Alnylam Pharmaceuticals 21
Not applicableLooking for participantsNCT06283082
What this trial is testing

Oxalate Excretion Profile in Patients with a Heterozygous Mutation of the AGXT (alanine-glyoxylate Aminotransferase) Gene

Who this might be right for
Hyperoxaluria (Disorder)
Hospices Civils de Lyon 25
Early research (Phase 1)Study completedNCT01621490
What this trial is testing

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Who this might be right for
Advanced MelanomaMetastatic Melanoma
Bristol-Myers Squibb 170
Testing effectiveness (Phase 2)Ended earlyNCT02102022
What this trial is testing

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Who this might be right for
Advanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more
Polaris Group 140
Early research (Phase 1)UnknownNCT00439504
What this trial is testing

Ph1 Lobeline Interaction Study - 1

Who this might be right for
Methamphetamine Dependence
National Institute on Drug Abuse (NIDA) 10
Early research (Phase 1)Looking for participantsNCT06943378
What this trial is testing

Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults

Who this might be right for
Pre-exposure Prophylaxis Against Pneumonic Plague in Healthy Adults
Just-Evotec Biologics 104
Not applicableNo Longer AvailableNCT05993416
What this trial is testing

Treatment of Primary Hyperoxaluria Type 1 With Nedosiran

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Early research (Phase 1)Ended earlyNCT00964834
What this trial is testing

Ph1 Study of Valortim and Doxycycline in Humans

Who this might be right for
Anthrax
PharmAthene, Inc. 24
Early research (Phase 1)WithdrawnNCT02757248
What this trial is testing

Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL

Who this might be right for
PTCLCTCL
Anne Beaven, MD
Load More Results